secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cabaletta Bio, Inc. (CABA)
CIK:        0001759138
Form:       8-K
Filed at:   2023-06-01T23:59:59+00:00
Accession:  0001193125-23-158936
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cabaletta Bio stockholders approve 3M share increase to 2019 equity plan, elect Scott Brun as director
--------------------------------------------------------------------------------

- Scott Brun, M.D. elected Class I director with 23.6M votes for, 1.2M withheld, serving until 2026 annual meeting.
- Amendment to 2019 Stock Option Plan approved, increasing authorized shares by 3,000,000 to 5,342,288.
- Ratification of Ernst & Young as independent auditor for FY2023 passed with 27.3M votes for.
- All proposals passed at June 1, 2023 Annual Meeting; no other matters voted on.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759138/000119312523158936/0001193125-23-158936-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759138/000119312523158936/d516711d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-158936

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer